Intellectual Property India Publishes Patent Application for 'Rna Inhibitor For Inhibiting Lpa Gene Expression And Use Thereof' Filed by Kylonova (XIAMEN) Biopharma Co. Ltd.

MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517044792 A) filed by Kylonova (XIAMEN) Biopharma Co. Ltd., Fujian, China, on May 8, for 'rna inhibitor for inhibiting lpa gene expression and use thereof.'

Inventor(s) include Cui Kunyuan; and Lu Xueqin.

The application for the patent was published on May 30, under issue no. 22/2025.

According to the abstract released by the Intellectual Property India: "Provided is an RNA inhibitor for inhibiting LPA gene expression or a pharmaceutically acceptable salt thereof. The RNA inhibitor is formed by base pairing of a sense strand and an antisense strand having a chain length of 15 30 and the chain length is preferably 19 23; at least 85% of bases of th...